Is screening for pancreatic cancer in high-risk groups cost-effective? - Experience from a Danish national screening program

Keyphrases

• High-risk Population 100%
• Pancreatic Cancer 100%
• National Screening Program 100%
• Familial Pancreatic Cancer 83%
• Incremental Cost-effectiveness Ratio 50%
• Pancreatic Ductal Adenocarcinoma 50%
• First-degree Relatives 16%
• Endoscopic Ultrasound 16%
• Screening Program 16%
• Early Detection 16%
• Stratified Analysis 16%
• Patient Relatives 16%
• Resection 16%
• Cancer Patients 16%
• Cost-effectiveness 16%
• Cancer Mortality 16%
• Cancer Causes 16%
• Cancer Cases 16%
• Genetic Disposition 16%
• Hereditary Pancreatitis 16%
• Total Pancreatectomy 16%
• Cardiac Surgery Complications 16%
• Cost-effective Intervention 16%

Medicine and Dentistry

• Health Care Cost 100%
• High Risk Population 100%
• Screening 100%
• Pancreas Cancer 100%
• Familial Pancreatic Cancer 83%
• Quality Adjusted Life Year 66%
• Pancreas Adenocarcinoma 50%
• Symptom 16%
• Heart Surgery 16%
• Surgery 16%
• Endoscopic Ultrasound 16%
• Pancreatitis 16%
• Cost-Effectiveness Analysis 16%
• Cancer Mortality 16%
• Pancreatectomy 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Pancreas Cancer 100%
• Pancreas Adenocarcinoma 27%
• Symptom 9%
• Cancer Mortality 9%
• Pancreatitis 9%